Tennessee appears as a setting where the distance to treatment, the organization of local partnerships, and resistance to new services shape the response to opioid addiction. Around Gray and the cities of Johnson City and Kingsport, a regional alliance worked to establish Overmountain Recovery, a clinic intended to combine medication with counseling and other support. In Bristol, a separate recovery center demonstrated another effort to connect treatment with housing, employment, and community institutions.

Regional Setting and Treatment Access

Overmountain Recovery was planned for a rural town between Johnson City and Kingsport. The location mattered to the service it was meant to provide: the nearest methadone facility was about sixty miles away, over a mountain. The clinic therefore answered a concrete geographic gap, rather than simply adding another program to an already accessible network.

The area’s treatment initiatives also took shape amid wider shortages of beds and providers. In the book’s account of the response to the crisis, people seeking help could encounter waiting lists, limited treatment capacity, and service rules that made it difficult to move from a crisis to ongoing care. Tennessee’s emerging partnerships offered a local response to those failures of access, although they did not make the broader obstacles disappear.

Overmountain Recovery and the Regional Alliance

The clinic was a project of the East Tennessee State University working group, an alliance of mental-health and substance-abuse administrators spearheaded by public-health professor Robert Pack. Its name joined a local historical reference—the Overmountain Men, farmers and frontiersmen associated with the Battle of Kings Mountain—with an expansive understanding of recovery. Treatment was intended to include group and individual counseling, yoga and other alternative therapies, and job-training support, rather than medication alone.

Overmountain Recovery was designed chiefly around Methadone maintenance treatment medication, given as a daily liquid dose in front of a nurse because it was less expensive and harder to divert; Suboxone was also planned as an eventual option. The working group’s wider effort had secured $2.5 million in grants, supported eight projects and twenty-five research proposals, and opened a Center for Prescription Drug Abuse focused on research. The clinic was one part of a growing institutional collaboration backed by the university, a regional nonprofit hospital corporation, and the state mental-health agency. It was co-led by Steve Loyd, a physician with local roots who had himself been addicted to opioids.

Bristol’s Recovery Model

Bristol Recovery Center offered another example of Tennessee’s community-based treatment infrastructure. Its director, Bob Garrett, helped turn a donated former nursing home into a 240-bed facility for people with addiction, veterans, young adults leaving foster care, and people returning from jail. He spent three years building relationships with local courts, police, churches, and social-service agencies. Participants would eventually pay to live there after finding work with the center’s help.

Garrett initially opposed allowing participants to receive Medication-assisted treatment, but changed his position after serving on a community coalition led by Robert Pack. He subsequently spoke to churches across the state about evidence-based treatment and the limits of treating addiction as a moral failing. The change illustrates a local shift in practice: collaboration exposed a treatment model to a wider community and altered the rules Garrett had first intended to impose.

Opposition and the Clinic’s Significance

Overmountain Recovery’s proposed site was Gray, a middle-class community of farmers and suburban residents, with Daniel Boone High School about a mile and a half away. Citizens to Maintain Gray, led by a respected local farmer, raised concerns that patients taking medication would be unsafe drivers. Some residents who opposed placing the clinic nearby privately acknowledged that addiction had affected their own families. The dispute thus combined fears about public safety and neighborhood proximity with recognition that the need for care was already present.

The working group met residents, brought in police chiefs and treatment providers from other communities, and presented examples and studies to local decision-makers. More than 300 people spoke against the project in a town of 1,222, and opponents sometimes denounced Pack and Loyd as drug dealers. After more than a year of contentious public debate, the clinic won near-unanimous approval from the city zoning board and state authorities, opening in September 2017. Tennessee’s role in the narrative is therefore not limited to the site of a new clinic: it is a case study in how treatment access can depend on distance, institutional cooperation, local persuasion, and the willingness to withstand sustained opposition.